Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
375K
-
Shares change
-
-13M
-
Total reported value, excl. options
-
$254K
-
Value change
-
-$4.84M
-
Number of buys
-
3
-
Number of sells
-
-35
-
Price
-
$0.68
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2025
39 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2025.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 375K shares
of 52.3M outstanding shares and own 0.72% of the company stock.
Largest 10 shareholders include RBF Capital, LLC (150K shares), Squarepoint Ops LLC (141K shares), XTX Topco Ltd (44.9K shares), KEMPNER CAPITAL MANAGEMENT INC. (25.5K shares), Ground Swell Capital, LLC (13.8K shares), Fort Vancouver Investment Management, LLC (0 shares), Shulman DeMeo Asset Management LLC (0 shares), VANGUARD GROUP INC (0 shares), Trivium Point Advisory, LLC (0 shares), and GEODE CAPITAL MANAGEMENT, LLC (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.